CVS Health is sliding in after-hours trading following a period of mixed sentiment regarding the company's near-term outlook. While the company recently highlighted that over 69 percent of its Medicare Advantage members are in plans rated 4 stars or higher for 2027, investors are simultaneously weighing ongoing concerns regarding 340B program pressures and expected declines in Caremark membership. This downward move follows a regular session where the stock outperformed the broader market, even as analysts noted the company has underperformed its medical sector peers by over 10 percent during the past month.